Viridian Therapeutics, Inc.\DE (VRDN) Gains from Investment Securities (2016 - 2024)
Historic Gains from Investment Securities for Viridian Therapeutics, Inc.\DE (VRDN) over the last 9 years, with Q4 2024 value amounting to $945000.0.
- Viridian Therapeutics, Inc.\DE's Gains from Investment Securities changed N/A to $945000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $496000.0, marking a year-over-year increase of 170000.0%. This contributed to the annual value of $496000.0 for FY2024, which is 170000.0% up from last year.
- Per Viridian Therapeutics, Inc.\DE's latest filing, its Gains from Investment Securities stood at $945000.0 for Q4 2024.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Gains from Investment Securities registered a high of $945000.0 during Q4 2024, and its lowest value of -$449000.0 during Q3 2024.
- Its 4-year average for Gains from Investment Securities is $29416.7, with a median of -$5000.0 in 2021.
- Examining YoY changes over the last 5 years, Viridian Therapeutics, Inc.\DE's Gains from Investment Securities showed a top increase of 85555.56% in 2020 and a maximum decrease of 32500.0% in 2020.
- Quarter analysis of 4 years shows Viridian Therapeutics, Inc.\DE's Gains from Investment Securities stood at -$1000.0 in 2020, then crashed by 100.0% to -$2000.0 in 2021, then skyrocketed by 50.0% to -$1000.0 in 2023, then skyrocketed by 94600.0% to $945000.0 in 2024.
- Its Gains from Investment Securities stands at $945000.0 for Q4 2024, versus -$449000.0 for Q3 2024 and -$1000.0 for Q2 2023.